- Home
- WYY vs DYAI Comparison
WYY vs DYAI Comparison
Compare WYY & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- DYAI
- Stock Information
- Founded
- WYY 1991
- DYAI 1979
- Country
- WYY United States
- DYAI United States
- Employees
- WYY N/A
- DYAI N/A
- Industry
- WYY EDP Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WYY Technology
- DYAI Health Care
- Exchange
- WYY Nasdaq
- DYAI Nasdaq
- Market Cap
- WYY 33.6M
- DYAI 28.3M
- IPO Year
- WYY 1998
- DYAI 2004
- Fundamental
- Price
- WYY $2.96
- DYAI $1.13
- Analyst Decision
- WYY Strong Buy
- DYAI Strong Buy
- Analyst Count
- WYY 1
- DYAI 1
- Target Price
- WYY $7.00
- DYAI $6.00
- AVG Volume (30 Days)
- WYY 58.6K
- DYAI 203.9K
- Earning Date
- WYY 08-14-2025
- DYAI 08-12-2025
- Dividend Yield
- WYY N/A
- DYAI N/A
- EPS Growth
- WYY N/A
- DYAI N/A
- EPS
- WYY N/A
- DYAI N/A
- Revenue
- WYY $142,582,209.00
- DYAI $3,554,344.00
- Revenue This Year
- WYY $9.05
- DYAI $22.56
- Revenue Next Year
- WYY $12.24
- DYAI $30.95
- P/E Ratio
- WYY N/A
- DYAI N/A
- Revenue Growth
- WYY 24.03
- DYAI 57.59
- 52 Week Low
- WYY $2.19
- DYAI $0.91
- 52 Week High
- WYY $6.25
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- WYY 41.39
- DYAI 62.78
- Support Level
- WYY $2.99
- DYAI $1.08
- Resistance Level
- WYY $3.23
- DYAI $1.20
- Average True Range (ATR)
- WYY 0.19
- DYAI 0.08
- MACD
- WYY -0.01
- DYAI 0.02
- Stochastic Oscillator
- WYY 27.59
- DYAI 50.00
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.